This enabled us to define the diploid population for calculation of tumor ploidy for each cancer specimen and also allowed us to assess the impact of brca2 mutation on DNA content and cell cycle progression in nonneoplastic somatic cells. The gene discussed is BRCA2; the disease is neoplasm.